Form S-3 60 DEGREES PHARMACEUTICA
http://archive.fast-edgar.com/20260814/AQ2J922CLZ22O24222ZA2CY2OKU8Z222428Q
Filed on: August 14, 2026
Form SCHEDULE 13G First Tracks Biotherapeu Filed by: TCG Crossover GP II, LLC
http://archive.fast-edgar.com/20260814/A32B222FZZ2RK2Z222JC2WYO44DHZZ22N282
Filed on: August 14, 2026
Form SCHEDULE 13G/A Abivax S.A. Filed by: TCG Crossover GP I, LLC
http://archive.fast-edgar.com/20260814/AB22S22FZZ2RV2Z222J42WYOPEKUEZ22N282
Filed on: August 14, 2026
Form SCHEDULE 13G/A BANK OF THE JAMES FINANC Filed by: Fourthstone LLC
http://archive.fast-edgar.com/20260814/AEZ2L22CZ224R2Z2222522Z4FTITCZ289282
Filed on: August 14, 2026
Form SCHEDULE 13G/A Faeth Therapeutics, Inc. Filed by: Caligan Partners LP
http://archive.fast-edgar.com/20260814/ALZZN22CQ222V2N2222Q22Z2ANJIZ2289P82
Filed on: August 14, 2026
More SEC Filings
View Older Stories-
Form SCHEDULE 13G/A ASSEMBLY BIOSCIENCES, Filed by: Paradigm Biocapital Advisors LP
-
Form SCHEDULE 13G Organon & Co. Filed by: Pentwater Capital Management LP
-
Form 13F-HR Hound Partners, LLC For: Jun 30
-
Form SCHEDULE 13G/A MASIMO CORP Filed by: Pentwater Capital Management LP
-
Form SCHEDULE 13G SPS COMMERCE INC Filed by: DISCIPLINED GROWTH INVESTORS INC /MN
-
Form SCHEDULE 13G/A SKYX Platforms Corp. Filed by: Alyeska Investment Group, L.P.
-
Form 25-NSE Myseum.AI, Inc. Filed by: Nasdaq Stock Market LLC
-
Form SCHEDULE 13G/A InflaRx N.V. Filed by: MONTANOVA CAPITAL, LLC
-
Form SCHEDULE 13G TXNM ENERGY INC Filed by: Pentwater Capital Management LP
-
Form N-PX Opus Capital Group, LLC For: Jun 30
-
Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Pentwater Capital Management LP
-
Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
-
Form 13F-NT Fortress Credit Opportun For: Jun 30
-
Form 10-Q BIOLARGO, INC. For: Jun 30
-
Form 13F-HR Ampersand Capital Group, For: Jun 30
-
Form 13F-NT Coatue Structured Co-Inv For: Jun 30
-
Form 13F-HR Greycroft LP For: Jun 30
-
Form 13F-NT Pershing Square Manageme For: Jun 30
-
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TCG Crossover GP II, LLC
-
Form SCHEDULE 13G/A Bleichroeder Acquisition Filed by: Alyeska Investment Group, L.P.
-
Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: MONTANOVA CAPITAL, LLC
-
Form SCHEDULE 13G/A BATTALION OIL CORP Filed by: Alyeska Investment Group, L.P.
-
Form 4 Arteris, Inc. For: Aug 12 Filed by: Hawkins Nicholas B.
-
Form 8-K OPKO HEALTH, INC. For: Aug 13
-
Form 8-K TUTOR PERINI CORP For: Aug 11
-
Form 13F-NT DME Advisors, LP For: Jun 30
-
Form 13F-NT Fortress Credit Opportun For: Jun 30
-
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: BIOTECHNOLOGY VALUE FUND L P
-
Form 13F-NT Greenlight Masters, LLC For: Jun 30
-
Form 13F-HR Foxhaven Asset Managemen For: Jun 30
-
Form 4 INTEL CORP For: Aug 11 Filed by: TAN LIP BU
-
Form SCHEDULE 13G/A Edgewise Therapeutics, Filed by: Paradigm Biocapital Advisors LP
-
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 13F-HR INFINITUM ASSET MANAGEME For: Jun 30
-
Form 13F-HR Mutual Advisors, LLC For: Jun 30
-
Form 13F-HR PERSHING SQUARE INC. For: Jun 30
-
Form 13F-NT FINCO I LLC For: Jun 30
-
Form SCHEDULE 13G/A SunPower Inc. Filed by: Alyeska Investment Group, L.P.
-
Form 10-Q Banzai International, For: Jun 30
-
Form 13F-HR D. E. Shaw & Co., Inc. For: Jun 30
-
Form 13F-NT Coatue Strategic Maple For: Jun 30
-
Form 144 Apollo Global Management Filed by: Kelly Martin
-
Form D Govably, Inc.
-
Form 144 Fifth District Bancorp, Filed by: Rittiner Chris M.
-
Form 13F-NT FINCO I Intermediate For: Jun 30
-
Form 4 URBAN ONE, INC. For: Aug 06 Filed by: Levingston Lemuel Deon
-
Form 13F-HR Situational Awareness For: Jun 30
-
Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: TCG Crossover GP II, LLC
-
Form 424B5 RIVERNORTH OPPORTUNITIES

